| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Third National Report on the implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
109447
Status
Published
Date of creation
2015-11-28 08:37 UTC (ddilovar@gmail.com)
Date of publication
2015-11-28 08:37 UTC (ddilovar@gmail.com)

This document is also available in the following languages:
Origin of report
1. Country
  • Tajikistan
Contact officer for report
Coordinates
Dr. Нейматулло Сафаров
Head
National Biodiversity and Biosafety Center (NBBC)
47 Shevchenko str.
Dushanbe
Tajikistan, 734025
Phone:+992 44 6002546,+992 37 2212546
Email:biodiv@biodiv.tojikiston.com,nsafarov@biodiv.tojikiston.com
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
National Biodiversity and Biosafety Center,
National Center for Implementation of National Environmental Action Plan,
Research Laboratory for Nature Protection,
Committee for Environmental Protection under the Government of the Republic of Tajikistan,
Academy of Sciences of the Republic of Tajikistan,
Tajik National University
Submission
10. Date of submission
2015-11-28
11. Time period covered by this report
Start date
2011-10-27
11. Time period covered by this report
End date
2015-10-31
Party to the Cartagena Protocol on Biosafety
Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
14. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
This question is relevant to indicators 1.1.1, 2.1.1, 2.1.2, and 3.1.2 of the Strategic Plan
  • A domestic regulatory framework is partially in place
15. If you indicated that a national biosafety framework exists in the above question, when did it become operational?
This question is relevant to the indicator 1.1.1 of the Strategic Plan
  • 2005
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • One or more national biosafety laws
  • One or more sets of biosafety guidelines
  • Other laws, regulations or guidelines that indirectly apply to biosafety
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • Yes
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • Yes
19. If you answered Yes to question 18, how many permanent staff members are in place whose functions are directly related to the national biosafety framework?
  • Less than 10
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • Yes
21. Here you may provide further details on the implementation of Article 2 in your country
The Republic of Tajikistan ratified the Cartagena Protocol, which is confirmed by the Decree of Majlisi Namoyandagon Majlisi Oli (Lower Parliament) of the Republic of Tajikistan "On ratification of the Cartagena Protocol on Biosafety to the Convention on Biological Diversity» № 932 dated 22.10.2003.

In April 2004, at national workshop with stakeholders responsible authorities developed and approved Biosafety Framework, which included the National Biosafety Framework.

Policy and legislative frameworks for the implementation of the Cartagena Protocol was adopted in February 2005 of the Law "On Biosafety" (Resolution by the Majlisi Milli Majlisi Oli (Higher Parliament) of the Republic of Tajikistan on the adoption of the Law "On biological safety», № 602 dated 11.02.2005 ).

National Biodiversity and Biosafety Center (NBBC), created by the Government of the Republic of Tajikistan in 2003 was a key agency for the implementation of obligations under the Cartagena Protocol and the establishment of coordination structures on Biosafety. NBBC responsible for liaison with the Secretariat of the Convention on Biological Diversity (CBD) and is working as the focal point for the formation of the Biosafety Clearing House Mechanism (BCH).

NBBC collaborated with the CBD Secretariat in the framework of the BCH to exchange information, maintains and updates the website, contacting national organizations and partners. Most of the work related to the provision of reports to the CBD Secretariat, the Government of the Republic of Tajikistan, the organization of seminars and meetings with partners, including the public and NGOs.

Despite the existence of legal means of implementation of laws in Tajikistan (Law on Biosafety), the institutional framework has not been created, but operates a diversified structure of preventive measures (various inspection services: pest control, variety testing, etc.). The NBBC in consultation with UNEP prepares and implements an appropriate project for the establishment of a national biosafety system in Tajikistan through the establishment and building of capacity, with the approval of the GEF.
Article 5 - Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • No
24. Here you may provide further details on the implementation of Article 5 in your country:
The Veterinary Institute of the Tajik Academy of Agricultural Sciences produces veterinary medicines by using biotechnology techniques. The relevant regulations and guidance documents regulate the work, including the transfer and adoption of such drugs. Special instructions or other regulatory documents on research or the use of LMOs / GMOs in veterinary medicine is not developed, in the absence of the appropriate technological equipment.

National Standards Agency received and placed two laboratory complex for the identification of LMOs, but due to the lack of regulations and agreements with other regulatory agencies have not yet started work. NBBC is currently developing a series of guidelines for the establishment of a system of biosafety in the Republic of Tajikistan.

For the development of scientific methods of biotechnology in the Tajik Agrarian University in 1997 and set up a Centre of biotechnology, which is a scientific laboratory. Special works on GMOs do not spend and do not participate in such studies due to lack of human capacity, modern biotechnology laboratory equipment and monitoring of GMOs.

Pharmaceutical (some) and medicines in the form of vaccines are imported within the framework of international treaties and monitored by WHO laboratories, and specialized agencies of the Ministry of Health of the Republic of Tajikistan.
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
This question is relevant to indicator 1.8.1 of the Strategic Plan
  • No
26. Does your country regulate the contained use of LMOs?
This question is relevant to indicators 1.1.2 and 1.8.2 of the Strategic Plan
  • No
28. Here you may provide further details on the implementation of Article 6 in your country:
Currently, in connection with the construction of new communication links Tajikistan became a cross-border with China, Afghanistan, Pakistan and Central Asian countries, although geographically is not convenient for global cross-border systems. After creating a biosafety system is planned to organize the monitoring on this issue.
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol OR a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
This question is relevant to indicators 1.1.2 and 3.1.4 of the Strategic Plan
  • Yes
30. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
32. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • No
33. Has your country established legal requirements for the accuracy of information contained in the notification?
  • No
34. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
This question is relevant to indicator 1.1.4 of the Strategic Plan
  • No
35. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
This question is relevant to indicator 1.1.5 of the Strategic Plan
  • No
38. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
39. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
46. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment
Previously designed instruction and training for customs services helped create a platform for cooperation NBBC with the State Customs Committee of the Republic of Tajikistan and its units engaged in checking documents at border posts for products of animal and vegetable origin. However, the lack of Tajikistan GMO control laboratories, hampers and restricts such cooperation. Without special center laboratory identification of GMOs, customs control during limited to a single product line, and only in some complex cases, based on consultation with other professionals.

It is planned to update training courses for border posts of customs services.

Facts of import of LMOs in the country are not officially registered. There were several newspaper articles about the possible import into the country of LMOs. There are no events for such items has been conducted, in the absence of precise information from journalists. The materials were printed on the assumptions.

This situation suggests that Tajikistan relying on the existing national regulatory framework, it is necessary to develop and adopt new internal measures for the implementation of the AIA procedure of the Protocol. Tajikistan has not developed a format for authorization (Article 10).

Government of the Republic of Tajikistan established under the leadership of Prime Minister Council on Food Security, which is a platform to promote the development of procedures and safeguards and the fundamental legal and regulatory framework for authorization systems.
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
47. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
This question is relevant to indicator 1.1.2 of the Strategic Plan
  • No
48. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • No
49. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
This question is relevant to indicator 3.1.5 of the Strategic Plan
  • No
50. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
This question is relevant to indicator 1.1.2 of the Strategic Plan
  • No
51. Has your country indicated its needs for financial and technical assistance and capacity-building in respect of LMOs-FFP?
This question is relevant to indicator 1.2.1 of the Strategic Plan
  • Yes
52. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • No
58. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP
All relevant documents, Tajikistan posted on the website of the BCH. Special regulations on the import of LMO-FFPs are not developed. An additional control - control of the epidemiological situation, which is performed by the State Sanitary and Epidemiological Service of the Ministry of Health of the Republic of Tajikistan, which has a corresponding instruction. This authority controls food safety based on the sanitary norms and rules, as well as the safety of medicines.

The country has no laboratory to identify the LMOs, in this regard, even in the markets identified products containing LMOs that are not regulated in any way in terms of the potential adverse effects.

BCH has been operating since 2007, view information about the newly emerged market of LMO-FFPs. As a rule, much of the procurement of food products for supermarkets by private entrepreneurs (owners of the supermarket) alone and a limited number of parties (for their stores). Buy them at the grocery wholesale warehouses (suppliers, but not producers). When importing products into the country is declared only by codes (Nomenclature codes) of customs services. This makes it difficult to monitor LMO. Back in 2005, Tajikistan in the preparation of the National Biosafety Framework has identified the problem of control of LMOs at the border crossing customs stations - the need for the introduction of LMOs in international codes of product lines. The mechanism is to develop solutions.
Article 12 – Review of decision
59. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • No
60. Has your country ever received a request for a review of a decision?
  • No
61. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
62. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
66. Here you may provide further details on the implementation of Article 12 in your country
Before the establishment of the biosafety system in the country and the acquisition of laboratory for the identification of LMOs are not available
Article 13 – Simplified procedure
67. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • No
68. Has your country ever applied the simplified procedure?
  • No
70. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
71. Here you may provide further details on the implementation of Article 13 in your country
Mechanis is under development
Article 14 – Bilateral, regional and multilateral agreements and arrangements
72. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • No
76. Here you may provide further details on the implementation of Article 14 in your country
Due to lack of a system multilateral dialogue on this issue are not carried out
Articles 15 & 16 – Risk Assessment and Risk Management
77. Has your country established a national framework for conducting risk assessments prior to taking decisions regarding LMOs?
  • No
79. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
This question is relevant to indicator 2.2.3 of the Strategic Plan
a) Risk assessment:
  • 100 or more
b) Management / Control:
  • 50 or more
c) Monitoring:
  • 50 or more
80. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
This question is relevant to indicator 2.2.5 of the Strategic Plan
  • No
81. Is your country using the "Manual on Risk Assessment of LMOs" (developed by CBD Secretariat) for training in risk assessment?
This question is relevant to indicator 2.2.5 of the Strategic Plan
  • No
82. Is your country using the "Guidance on Risk Assessment of LMOs" (developed by the Online Forum and the AHTEG on Risk Assessment and Risk Management) for training in risk assessment?
This question is relevant to indicator 2.2.5 of the Strategic Plan
  • No
83. Are the currently available training materials or technical guidance on risk assessment and/or risk management of LMOs sufficient?
This question is relevant to indicator 2.2.6 of the Strategic Plan
  • No
84. Does your country have the capacity to detect, identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
This question is relevant to indicators 1.4.2 and 1.6.3 of the Strategic Plan
a) Detect:
  • Yes
b) Identify:
  • Yes
c) Assess:
  • No
d) Monitor:
  • No
85. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment or risk management, or for evaluating risk assessment reports submitted by notifiers?
This question is relevant to indicators 1.3.1 of the Strategic Plan
a) Risk assessment:
  • No
b) Risk management:
  • No
86. Is your country using the "Guidance on Risk Assessment of LMOs" (developed by the Online Forum and the AHTEG on Risk Assessment and Risk Management) for conducting risk assessment or risk management, or for evaluating risk assessment reports submitted by notifiers?
This question is relevant to indicator 2.2.5 of the Strategic Plan
  • No
87. Has your country adopted any common approaches to risk assessment with other countries?
This question is relevant to indicator 1.3.2 of the Strategic Plan
  • No
88. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
This question is relevant to indicator 1.4.1 of the Strategic Plan
  • No
89. Has your country ever conducted a risk assessment of an LMO including any type of risk assessment of LMOs, e.g. for contained use, field trials, commercial purposes, direct use as food, feed, or for processing?
This question is relevant to indicator 1.3.3 of the Strategic Plan
  • No
94. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • No
95. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • No
96. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
This question is relevant to indicator 2.2.4 of the Strategic Plan
  • No
97. Here you may provide further details on the implementation of Articles 15 and 16 in your country
The country is at the stage of organization. Special standards for risk assessment in Tajikistan has not been made, which is directly related to the lack of laboratory on monitoring of LMOs.

A small number of experts who can participate at the national level in the activities of the risk assessment are at various scientific departments and organizations.
Article 17 – Unintentional transboundary movements and emergency measures
98. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • No
99. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • No
100. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
This question is relevant to indicator 1.8.3 of the Strategic Plan
  • No
101. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
105. Here you may provide further details on the implementation of Article 17 in your country
Regulatory documents on regulation of movement according to the law of the Republic of Tajikistan "On Biosafety" are under development
Article 18 – Handling, transport, packaging and identification
106. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • No
107. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
This question is relevant to indicator 1.6.1 of the Strategic Plan
  • No
108. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
This question is relevant to indicator 1.6.1 of the Strategic Plan
  • No
110. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
This question is relevant to indicator 1.6.2 of the Strategic Plan
  • No
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
This question is relevant to indicator 1.6.2 of the Strategic Plan
  • No
114. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
This question is relevant to indicator 1.6.4 of the Strategic Plan
  • No
115. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • No
116. How many customs officers in your country have received training in the identification of LMOs?
This question is relevant to indicator 2.3.1 of the Strategic Plan
  • 50 or more
117. Has your country established procedures for the sampling and detection of LMOs?
  • No
118. How many laboratory personnel in your country have received training in detection of LMOs?
This question is relevant to indicator 2.3.1 of the Strategic Plan
  • 50 or more
119. Does your country have reliable access to laboratory facilities for the detection of LMOs?
This question is relevant to indicator 2.3.2 of the Strategic Plan
  • No
120. How many laboratories in your country are certified for LMO detection?
This question is relevant to indicator 2.3.3 of the Strategic Plan
  • None
122. Here you may provide further details on the implementation of Article 18 in your country:
Tajikistan is at the very beginning of the process of development of regulatory documents, and now it is not acceptable at the country level
Article 19 – Competent National Authorities and National Focal Points
123. In case your country has designated more than one competent national authority, has your country established a mechanism for the coordination of their actions prior to taking decisions regarding LMOs?
  • No
124. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • Yes
125. Here you may provide further details on the implementation of Article 19 in your country
In Tajikistan, in the implementation of the provisions of the Cartagena Protocol on Biosafety to the Convention on Biological Diversity, the following state agencies are identified: the National Biodiversity and Biosafety Center - as a national body on fulfillment of obligations under the Convention on Biodiversity and the Cartagena Protocol, and is responsible for maintaining the BCH Tajikistan; Committee on Environmental Protection under the Government of the Republic of Tajikistan - the body responsible for the conduction of monitoring of the environment; Control Services of the Ministry of Agriculture of the Republic of Tajikistan, the scientific division of academic institutions of Tajik Agricultural Academy of Sciences and the Academy of Sciences of the Republic of Tajikistan - conduct scientific work in the field of genetics; Customs Service under the Government of the Republic of Tajikistan - is the overall monitoring of the export-import.

In Tajikistan in 2011, the Council on Food Security, chaired by the Prime Minister of the Republic of Tajikistan has been established. After the formation of the functions of the Council, it is expected to determine the area of ​​responsibility in the implementation of the Cartagena Protocol through joint participation in the national biosafety framework of the Republic of Tajikistan.
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
126. Please provide an overview of the status of the mandatory information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
This question is relevant to indicator 3.1.5 of the Strategic Plan
a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information available and in the BCH
b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information available and in the BCH
c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information not available
d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available and in the BCH
e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information not available
f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information not available
j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information not available
k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information not available
l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information not available
m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information not available
n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information available and in the BCH
o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information not available
127. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • Yes
128. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • Yes
129. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • Yes, in some cases
130. Has your country experienced difficulties accessing or using the BCH?
This question is relevant to indicator 4.1.8 of the Strategic Plan
  • No
131. Is the information submitted by your country to the BCH complete and up-to date?
  • Yes
132. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years:
This question is relevant to indicator 4.3.1 of the Strategic Plan
  • 10 or more
133. Please indicate the number of biosafety related publications that has been made available in your country in the last year:
This question is relevant to indicator 4.3.2 of the Strategic Plan
  • One or more
134. If biosafety related publications were made available (see question above), please indicate which modalities were preferred:
This question is relevant to indicator 4.3.2 of the Strategic Plan
  • National Libraries
  • BCH Central Portal
135. Here you may provide further details on the implementation of Article 20 in your country
Capacity-building activities and the development of BCH in Tajikistan allowed to form an understanding of responsible organizations about the importance of the Cartagena Protocol and to teach methods of obtaining information. However, so far failed to generate the interest of the responsible organizations to provide timely information. It is anticipated that this will develop special instructions and recommendations to the responsible authorities of the Republic of Tajikistan on Biosafety.
Article 21 – Confidential information
136. Has your country established procedures to protect confidential information received under the Protocol?
  • Yes
137. Does your country allow the notifier to identify information that is to be treated as confidential?
  • Yes, always
138. Here you may provide further details on the implementation of Article 21 in your country
In Tajikistan, according to the Law on Biosafety and the law of confidential information, any information about biosafety fall under these laws, coordinated with specially authorized bodies.
Article 22 – Capacity-building
139. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
This question is relevant to indicator 1.2.6 and 3.1.8 of the Strategic Plan
  • Yes
140. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
141. If you answered Yes to question 140, how were these resources made available?
  • Bilateral channels
142. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
143. If you answered Yes to question 142, how were these resources made available?
  • Bilateral channels
144. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • Yes
145. If you answered Yes to question 144, how would you characterize the process?
Please add further details about your experience in accessing GEF funds under question 157.
  • Average
146. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Implementation of national biosafety frameworks
147. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
148. If you answered Yes to question 147, in which of the following areas were these activities undertaken?
  • Identification of LMOs, including their detection
149. During the current reporting period, has your country carried out a capacity-building needs assessment?
This question is relevant to indicator 1.2.1 of the Strategic Plan
  • Yes
150. If you answered Yes to question 149, has this information been submitted to the BCH?
This question is relevant to indicator 1.2.1 of the Strategic Plan
  • Yes
151. Does your country still have capacity-building needs?
This question is relevant to indicator 1.2.7 of the Strategic Plan
  • Yes
152. If you answered Yes to question 151, indicate which of the following areas still need capacity-building.
  • Institutional capacity
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Technology transfer
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Handling of confidential information
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
153. Has your country developed a capacity-building strategy or action plan?
This question is relevant to indicator 1.2.2 of the Strategic Plan
  • No
154. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
This question is relevant to indicator 1.2.4 of the Strategic Plan
  • No
155. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
This question is relevant to indicator 1.2.3 of the Strategic Plan
  • None
156. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • Yes
157. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds
Currently implemented the Project GEF-UNEP «Support for the preparation of the Third National Report on the Cartagena Protocol on Biosafety.

Objective: Analysis of the effectiveness of the National Biosafety Framework of Tajikistan, operating under the Cartagena Protocol on Biosafety; definition of the main activities of the responsible authorities and stakeholders to strengthen the development and functioning of the national biosafety framework. The main objective - the development of national reporting to strengthen national biosafety frameworks and the implementation of obligations of the Republic of Tajikistan on the implementation of the Cartagena Protocol in accordance with Article 33 of the protocol, as well as placement on the website of the BCH Tajikistan the Third National Report on the implementation of the Cartagena Protocol.

In addition, Tajikistan has successfully cooperated with GEF agencies and with the support of international consultants provided by UNEP has prepared a project to support the implementation of the National Biosafety Framework. The request for funding is supported and endorsed by the GEF. The active phase of the project support the implementation of the National Biosafety Framework is being finalized. The project will create a specialized laboratory for monitoring the LMO, to strengthen national capacities through the development of a number of important legal documents on the procedures regulated under the Cartagena Protocol and national legislation.

Earlier, the National Center for biodiversity and biosafety carried out joint projects of the Government of the Republic of Tajikistan and the United Nations Environment Programme (UNEP) 2003-2005 years. «Development of National Biosafety Framework for the Republic of Tajikistan» in 2006-2007. - «Capacity Building for effective participation in the Biosafety Clearing-House Mechanism» which resulted in the development of a national biosafety framework and the necessary conditions for participation in the Biosafety Clearing-House Mechanism.
Article 23 – Public awareness and participation
158. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to some extent
Here you may provide further details
The media carried special programs on Biosafety under the Cartagena Protocol
159. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
This question is relevant to indicator 5.3.2 of the Strategic Plan
  • No
160. Does your country have any awareness and outreach programmes on biosafety?
This question is relevant to indicator 5.3.1 of the Strategic Plan
  • Yes
161. If you answered Yes to question 160, please indicate what entity is responsible for carrying out the programmes and/or services and at which level the programmes take place (e.g. local, national, etc.):
This question is relevant to indicator 5.3.1 of the Strategic Plan
At this stage there is no special program on biosafety capacity building. At the same time, constantly in the media carried out special programs on Biosafety under the Cartagena Protocol.
162. Has your country established a biosafety website searchable archives, national resource centres or sections in existing national libraries dedicated to biosafety educational materials?
This question is relevant to indicators 2.5.3 and 5.3.3 of the Strategic Plan
  • Yes
163. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
This question is relevant to indicator 5.2.1 of the Strategic Plan
  • 5 or more
164. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • Yes
165. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
This question is relevant to indicator 2.5.1 of the Strategic Plan
  • Yes
166. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
This question is relevant to indicator 2.5.1 of the Strategic Plan
  • No
167. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
This question is relevant to indicator 2.5.2 of the Strategic Plan
  • Yes
168. If you answered Yes to question 167, please indicate the modalities used to inform the public:
This question is relevant to indicator 2.5.2 of the Strategic Plan
  • National website
  • Newspaper
  • Forums
169. If you indicated more than one modality for public participation in question 168, which one was most used?
This question is relevant to indicator 2.5.2 of the Strategic Plan
  • National website
170. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • Yes
171. How many academic institutions in your country are offering biosafety education and training courses and programmes?
This question is relevant to indicator 2.7.1 of the Strategic Plan
  • 3 or more
172. Please indicate the number of educational materials and/or online modules on biosafety that are available and accessible to the public in your country:
This question is relevant to indicators 2.7.2 and 5.3.4 of the Strategic Plan
  • None
173. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes
174. If you answered Yes to question 173, has your country cooperated with other States and international bodies?
  • Yes
175. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • More than 5
176. Here you may provide further details on the implementation of Article 23 in your country
In Tajikistan, developed a website http://www.biodiv.tj, which contains materials on biosafety and biodiversity of the Republic of Tajikistan. The site is supported by National Biodiversity and Biosafety Center. New materials placed on the site and the interested public can review and send their contributions on various issues.
Article 24 – Non-Parties
177. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
178. Has your country ever imported LMOs from a non-Party?
  • No
179. Has your country ever exported LMOs to a non-Party?
  • No
183. Here you may provide further details on the implementation of Article 24 in your country:
Tajikistan in 2015, joined the WTO, and in connection with its obligations country will maintain agreements with the country-members of the WTO
Article 25 – Illegal transboundary movements
184. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • No
185. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • No
186. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
If you replied Never to question 186 please go to question 191
  • Never
191. Here you may provide further details on the implementation of Article 25 in your country
Tajikistan is at the stage of creating a system of biosafety, and will introduce the requirements of this Article
Article 26 – Socio-economic considerations
192. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
This question is relevant to indicator 1.7.2 of the Strategic Plan
  • No
193. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • Not applicable
194. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
This question is relevant to indicator 1.7.1 of the Strategic Plan
  • None
195. What is your country's experience, if any, in taking socio-economic considerations into account in LMO decision making? Please give details:
This question is relevant to indicator 1.7.3 of the Strategic Plan
In the absence of biosafety system, the country is developing a legal framework for the implementation of this Article
196. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • No
197. Here you may provide further details on the implementation of Article 26 in your country
Tajikistan is studying the experience of other countries on this Article
Article 27 – Liability and Redress
198. Has your country ratified or acceded to the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • No
199. If you answered No to question 198, is there any national process in place towards becoming a Party?
  • Yes
200. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
This question is relevant to indicator 2.4.1 of the Strategic Plan
  • Yes
201. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
This question is relevant to indicators 1.5.2 and 2.4.2 of the Strategic Plan
  • No
202. Here you may provide further details on any activities undertaken in your country towards the implementation of the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress
Tajikistan is consulting with stakeholders on the issue of the signing of this protocol
Article 28 – Financial Mechanism and Resources
203. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
This question is relevant to indicator 1.2.5 of the Strategic Plan
  • Less than 5,000 USD
Article 33 – Monitoring and reporting
204. Does your country have in place a monitoring and/or an enforcement system for the implementation of the Cartagena Protocol?
This question is relevant to indicator 3.1.6 of the Strategic Plan
a) Monitoring system:
  • No
b) Enforcement system:
  • No
205. Has your country submitted all the previous due National Reports?
  • Yes
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
Policy of the Republic of Tajikistan in the field of biosafety is just being formed. Currently, it is based on the fundamental principles enshrined in the relevant acts of national legislation. New competent authority in the structure of the National Biosafety Framework in terms of food security began its operation in 2011 and is headed by the Prime Minister of the Republic of Tajikistan.

Currently in Tajikistan there is the restructuring of the Academy of Sciences of the Republic of Tajikistan and the association of specialized institutions. Upon completion of the program will develop new research, including biotechnology fields.

Specialized Center for Biotechnology of the Tajik Academy of Agricultural Sciences of the Ministry of Agriculture carries out a limited number of studies on biotechnology for the improvement of seed. However, technological and laboratory capacities are extremely limited.

Research Institute of Veterinary preparing vaccines for farm animals and is working on biotechnology with a number of countries participating in joint research programs.